case_images: PMC6834387_01
case_images: Landscape of papillary carcinoma with two components: bottom left the Warthin-like and upper middle-right the sclerosing ones.
case_images: can-13-965fig6.jpg
case_images: PMC6834387_01_can-13-965fig6.jpg
case_images: figure6
case_images: The sclerosing variant of papillary carcinoma with inflammation, sclerosis.
case_images: can-13-965fig7.jpg
case_images: PMC6834387_01_can-13-965fig7.jpg
case_images: figure7
case_images: While the last area resembled a WTL-PTC (Warthin Like-Papillary Thyroid Carcinoma) (Figure 2A), the first component was similar to the diffuse sclerosing variant of PTC (Figure 2B).
case_images: Papillary carcinoma another Warthin-like features.
case_images: can-13-965fig8.jpg
case_images: PMC6834387_01_can-13-965fig8.jpg
case_images: figure8
case_images: We detected an intense immunoreactivity for cytokeratin 19 and Galectin-3 (Figure 3) in every neoplastic cell and a focal positivity for p40 in few neoplastic cells in sclerosing areas (Figure 4).
case_images: Papillary carcinoma sclerosing variant.
case_images: can-13-965fig9.jpg
case_images: PMC6834387_01_can-13-965fig9.jpg
case_images: figure9
case_images: We detected an intense immunoreactivity for cytokeratin 19 and Galectin-3 (Figure 3) in every neoplastic cell and a focal positivity for p40 in few neoplastic cells in sclerosing areas (Figure 4).
case_images: Papillary carcinoma Warthin-like merging with sclerosing ones.
case_images: can-13-965fig10.jpg
case_images: PMC6834387_01_can-13-965fig10.jpg
case_images: figure10
case_images: No RET-fusion genes were identified by NGS (Figure 5).